Overview


Antiretroviral therapy (ART) is the treatment of individuals infected with HIV (human immunodeficiency virus) using anti-HIV drugs. The traditional treatment comprises a combination of drugs (called HAART or "highly active antiretroviral therapy") that suppress the replication of the virus in the body. The combination of medications is used to increase potency and reduce the chance of the virus developing resistance. Antiretroviral therapy reduces mortality and morbidity rates among HIV-infected individuals and improves their quality of life. The advantages of ART also include the prevention of HIV transmission by suppressing HIV replication in individuals living with the virus. This advantage of ART is also defined as "undetectable equal untransmittable," or U=U. ART aims to reduce the viral load (the quantity of HIV in the blood) to undetectable levels. When the virus is effectively suppressed, it cannot replicate, and the immune system is able to recover.

Based on the route of administration, antiretroviral drugs can be categorized into oral and intravenous administration. Orally, tablets and capsules are the most common forms of antiretroviral drugs. They are taken orally with water and can be administered at home. Depending on the specific drug and regimen, they may be taken once or multiple times a day. Also, some antiretroviral drugs can be administered intravenously in a healthcare setting. This may be necessary in cases where oral administration is not possible or when a more rapid and controlled absorption is required.

FutureWise Market Research has published a report that provides an insightful analysis antiretroviral therapy market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts antiretroviral therapy market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Gilead
  • F. Hoffmann-La Roche
  • ViiV Healthcare
  • Boehringer Ingelheim
  • Janssen Pharmaceuticals
  • Mylan
  • Abbvie
  • Bionor Pharma
  • Vertex Pharmaceuticals

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of HIV/AIDS is expected to increase the demand for antiretroviral therapy. With a substantial and sustained population affected by the virus worldwide, the demand for potent and efficient antiretroviral drugs has never been more pronounced. As the number of individuals suffering from HIV continues to rise, healthcare experts increasingly rely on these therapies to manage the condition and enhance the quality of life for those affected. This perpetual need emphasizes the critical role of antiretroviral drugs in the global battle against HIV/AIDS, making them an indispensable component of contemporary healthcare strategies. Also, the development of combination therapies represents promising drivers in antiretroviral therapy. By integrating multiple antiretroviral drugs into a single, streamlined formulation, the potential for markedly improved treatment efficacy and patient compliance lies. This innovative approach simplifies complicated medication regimens and addresses potential drug resistance issues. It's foreseen that the development and adoption of such combination therapies could not only revolutionize the standard of care for HIV patients but also stimulate significant growth in antiretroviral therapy. Thus boosting the target market during the forecast period. However, the high cost of these therapies may stand as a significant barrier to antiretroviral therapy. Particularly with the advent of unique and more advanced formulations, the price tags associated with these drugs may be excessive. This economic burden constitutes a significant constraint, especially for individuals in resource-limited settings where healthcare resources are already extended. The high cost of antiretroviral drugs may result in limited access, leaving many individuals without the means to procure necessary treatment, further restraining the market growth.

By Drug Class

  • Multi-Class Drugs Combination Drugs
  • Nucleoside reverse transcriptase inhibitors
  • Non-nucleoside reverse transcriptase inhibitors
  • Protease inhibitors
  • Others

By Route Of Administration

  • Oral route administration
  • Intravenous

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacy
  • Drug stores
  • Online

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the rising incidences of HIV infection, growing cases of sexually transmitted diseases, high research and development, high healthcare expenditure, skilled professionals, and use of infected syringes & blood products, and family history with HIV infection in the area will increase the demand for antiretroviral therapy market growth. In addition, the easy availability of diagnosis tests and treatments, the presence of key product manufacturers, technologically advanced production facilities, and patient’s awareness regarding diseases and treatment will propel the target market. Therefore, the above-mentioned factors are projected to boost the growth of the antiretroviral therapy market over the forecast period in the region.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Antiretroviral Therapy Market By Drug Class, By Route Of Administration, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antiretroviral Therapy Market Variables, Trends and Scope

    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antiretroviral Therapy Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antiretroviral Therapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antiretroviral Therapy Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Multi-Class Drugs Combination Drugs
        2. Nucleoside reverse transcriptase inhibitors
        3. Non-nucleoside reverse transcriptase inhibitors
        4. Protease inhibitors
        5. Others

  • 8.   Antiretroviral Therapy Market, By Route Of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Oral route administration
        2. Intravenous

  • 9.   Antiretroviral Therapy Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital pharmacies
        2. Retail pharmacy
        3. Drug stores
        4. Online

  • 10.   North America Antiretroviral Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Antiretroviral Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Antiretroviral Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Antiretroviral Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Gilead
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffmann-La Roche
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. ViiV Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boehringer Ingelheim
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Janssen Pharmaceuticals
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mylan
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbvie
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bionor Pharma
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Vertex Pharmaceuticals
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11